These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7949790)

  • 1. The effect of dietary caffeine manipulation on blood caffeine, sleep and disturbed behaviour.
    Searle GF
    J Intellect Disabil Res; 1994 Aug; 38 ( Pt 4)():383-91. PubMed ID: 7949790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a low phenylalanine diet with amino acid supplement in the treatment of behavioural problems in a severely mentally retarded adult female with phenylketonuria.
    Hoskin RG; Sasitharan T; Howard R
    J Intellect Disabil Res; 1992 Apr; 36 ( Pt 2)():183-91. PubMed ID: 1591502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is caffeine a factor in subjective insomnia of elderly people?
    Curless R; French JM; James OF; Wynne HA
    Age Ageing; 1993 Jan; 22(1):41-5. PubMed ID: 8438665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers.
    Hughes JR; Higgins ST; Bickel WK; Hunt WK; Fenwick JW; Gulliver SB; Mireault GC
    Arch Gen Psychiatry; 1991 Jul; 48(7):611-7. PubMed ID: 2069491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-related sleep disturbance and polysomnographic response to caffeine.
    Drake CL; Jefferson C; Roehrs T; Roth T
    Sleep Med; 2006 Oct; 7(7):567-72. PubMed ID: 16996309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary caffeine on mood when rested and sleep restricted.
    James JE; Gregg ME
    Hum Psychopharmacol; 2004 Jul; 19(5):333-41. PubMed ID: 15252825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobehavioral hazard identification and characterization for caffeine.
    Turnbull D; Rodricks JV; Mariano GF
    Regul Toxicol Pharmacol; 2016 Feb; 74():81-92. PubMed ID: 26702789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging sleep in aging: the effects of 200 mg of caffeine during the evening in young and middle-aged moderate caffeine consumers.
    Drapeau C; Hamel-Hébert I; Robillard R; Selmaoui B; Filipini D; Carrier J
    J Sleep Res; 2006 Jun; 15(2):133-41. PubMed ID: 16704567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours: discontinuation study.
    Haessler F; Glaser T; Beneke M; Pap AF; Bodenschatz R; Reis O;
    Br J Psychiatry; 2007 May; 190():447-8. PubMed ID: 17470962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine administration at night during extended wakefulness effectively mitigates performance impairment but not subjective assessments of fatigue and sleepiness.
    Paech GM; Banks S; Pajcin M; Grant C; Johnson K; Kamimori GH; Vedova CB
    Pharmacol Biochem Behav; 2016 Jun; 145():27-32. PubMed ID: 27061779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buspirone alone or with serotonergic diet reduced aggression in a developmentally disabled adult.
    Gedye A
    Biol Psychiatry; 1991 Jul; 30(1):88-91. PubMed ID: 1892965
    [No Abstract]   [Full Text] [Related]  

  • 12. Caffeine gum minimizes sleep inertia.
    Newman RA; Kamimori GH; Wesensten NJ; Picchioni D; Balkin TJ
    Percept Mot Skills; 2013 Feb; 116(1):280-93. PubMed ID: 23829154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary caffeine, performance and mood: enhancing and restorative effects after controlling for withdrawal reversal.
    James JE; Gregg ME; Kane M; Harte F
    Neuropsychobiology; 2005; 52(1):1-10. PubMed ID: 15942257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine and aggression.
    Carmel H
    Hosp Community Psychiatry; 1991 Jun; 42(6):637-9. PubMed ID: 1741835
    [No Abstract]   [Full Text] [Related]  

  • 15. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions.
    Evans SM; Griffiths RR
    J Pharmacol Exp Ther; 1999 Apr; 289(1):285-94. PubMed ID: 10087016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
    Wesensten NJ; Belenky G; Kautz MA; Thorne DR; Reichardt RM; Balkin TJ
    Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Caffeine Ingestion during Evening Exercise on Subsequent Sleep Quality in Females.
    Ali A; O'Donnell JM; Starck C; Rutherfurd-Markwick KJ
    Int J Sports Med; 2015 Jun; 36(6):433-9. PubMed ID: 25700100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary caffeine on EEG, performance and mood when rested and sleep restricted.
    Keane MA; James JE
    Hum Psychopharmacol; 2008 Dec; 23(8):669-80. PubMed ID: 18980263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal syndrome after the double-blind cessation of caffeine consumption.
    Silverman K; Evans SM; Strain EC; Griffiths RR
    N Engl J Med; 1992 Oct; 327(16):1109-14. PubMed ID: 1528206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
    Le Jeunne C; Gómez JP; Pradalier A; Titus i Albareda F; Joffroy A; Liaño H; Henry P; Lainez JM; Geraud G
    Eur Neurol; 1999 Jan; 41(1):37-43. PubMed ID: 9885327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.